Bruker, a provider of scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis, has reported revenues of $300.9m for the second quarter ended June 30, 2010, an increase of 19%, compared to $252.5m for the comparable period in 2009.
Subscribe to our email newsletter
Bruker has posted a net income of $22.6m for the second quarter 2010, or $0.14 per diluted share, compared to net income of $12.9, or $0.08 per diluted share, for the comparable period in 2009. Operating income was $37.9m, compared to $20.2m for the comparable period in 2009.
For the six months ended June 30, 2010, Bruker has posted revenue of $578.6m compared to $483m for the year ago period. Operating income was $64.8m, compared to $34.5m for the year ago period.
Bruker has posted a net income of $38.7m, or $0.23 per diluted share for six months ended June 30, 2010, compared to $21.3m, or $0.13 per diluted share, for the year ago period.
Frank Laukien, president and CEO of Bruker, said: “We are extremely pleased with both our second quarter and half year results, with record first half revenues, operating income and earnings per share.
“For the second quarter in a row all four operating divisions in our Scientific Instruments segment delivered double-digit organic growth year-over-year.
“We monitor academic and government research budgets in Europe, and we believe that overall these will continue to be stable or growing.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.